期刊文献+

四氯合钯(Ⅱ)喹诺酮配合物的合成及与DNA的作用和抗增殖活性 被引量:3

Synthesis and Interaction with DNA and Antiproliferative Activities of Complexes of Quinolones with Tetrachloropalladium(Ⅱ)
原文传递
导出
摘要 在酸性条件下,分别合成了四氯合钯(Ⅱ)离子与2种喹诺酮(诺氟沙星,NFLX=C16H18N3O3F;环丙沙星,CPLX=C17H18N3O3F)离子形成的配合物(NFLXH)2[PdCl4]·2H2O(1)和(CPLXH)2[PdCl4]·2H2O(2).用元素分析、IR、UV以及摩尔电导测定等方法对其进行了表征.配合物1的晶体结构经X射线单晶衍射确定,结构参数:三斜晶系,P-1空间群,a=0.84561(17)nm,b=0.94191(19)nm,c=1.2832(3)nm;α=111.26(3)°,β=97.23(3)°,γ=96.38(3)°,V=0.9312(4)nm3,Z=1,最后吻合因子R=0.040,wR=0.088.利用紫外光谱法、荧光光谱法对配合物与小牛胸腺DNA(ct-DNA)的作用进行了研究,研究表明,配合物对DNA的作用模式为插入作用,与DNA的结合常数Kb分别为:Kb(1)=2.06×104,Kb(2)=2.43×104.其后测试了配合物对体外肿瘤细胞的抗增殖活性.经采用四甲基偶氮唑蓝分析法(MTT法)测试后发现配合物1和2对人肺腺癌A549细胞、人原髓细胞白血病HL-60细胞的增殖抑制作用显著强于相应的喹诺酮分子本身,其中配合物2对人肺腺癌A549细胞增殖有明显的抑制作用,抑制率可高达(95.4±3.7)%,半数抑制浓度(IC50,72h)为(124.5±10.3)μmol·L-1. The complexes of norfloxacin (NFLX=C16H18FN3O3), ciprofloxacin (CPLX=C17H18FN3O3) with palladium ion [(NFLXH)2[PdCl4]·2H2O (1), (CPLXH)2[PdCl4]·2H2O (2)] were synthesized under an acidic condition. Complex 1 is orange crystal and complex 2 is brown powder. By means of elemental analysis, IR, UV and molar conductance, the structures of the complexes were characterized. The structure of 1 was determined by single crystal X-ray crystallography, which is of triclinic space group P-1 with a= 0.84561(17) nm, b=0.94191(19) nm, c= 1.2832(3) nm; α= 111.26(3)°, β=97.23(3)°, γ=96.38(3)°, V= 0.9312(4) nm^3, Z= 1, R=0.040 and wR=0.088. The interactions between the complexes and ct-DNA were studied by ultraviolet absorption spectroscopy and fluorescence spectroscopy, indicating that the binding mode is intercalation and the binding constants (Kb) of the complexes with DNA respectively is: 2.06 × 10^4 (1), 2.43 × 10^4 (2). Antiproliferative activities of the complexes to tumors in vitro were tested by using an 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) method, showing that the complexes have more powerful inhibition effects on A549 cells and on HL-60 cells growth than quinolone itself. 2 has obvious inhibition effect on A549 cells growth: inhibition ratio on A549 cells reached (95.4 ±3.7)% and its IC50(72 h) on A549 cells was (124.5± 10.3) μmol,L^-1.
出处 《化学学报》 SCIE CAS CSCD 北大核心 2009年第14期1573-1578,共6页 Acta Chimica Sinica
基金 国家自然科学基金(No.20173050)资助项目
关键词 喹诺酮 诺氟沙星 环丙沙星 钯(Ⅱ) DNA 抗增殖活性 quinolone norfloxacin ciprofloxacin palladium DNA antiproliferative activity
  • 相关文献

参考文献18

  • 1宋晓坤,蒋惠留.氟喹诺酮类药物综述[J].中国医院药学杂志,1994,14(1):31-32. 被引量:23
  • 2王国平,傅旭春,朱龙观.双核铜(Ⅱ)-氟喹诺酮-邻菲咯啉混配配合物的合成、晶体结构和抗肿瘤活性[J].无机化学学报,2003,19(9):1001-1005. 被引量:11
  • 3Chen,Z.-F.; Xiong,R.-G.; Zuo,J.-L.; Guo,Z.-J.; You,X.-Z.; Fun,H.-K.J.Chem.Soc.,Dalton Trans.2000,4013.
  • 4Chen,Z.-F.; Li,B.-Q.; Xie,Y.-R.; Xiong,R.-G.; You,X.-Z.; Feng,X.-L.lnorg.Chem.Commun.2001,4,346.
  • 5Turel,I.; Leban,I.; Zupaneic,M.; Bukovec,P.; Gruber,K.Acta Crystallogr.Sect.C 1996,52,2443.
  • 6Xia,Y.; Yang,Z.-Y.; Susan L,M.-N.; Lee,K.-H.Curr.Med.Chem.1999,6,179.
  • 7Jamil,A.-M.; Tashtoush,B.J.Coord.Chem.2003,56,113.
  • 8Jamil,A.-M.Acta Chim.Slov.2002,49,457.
  • 9Zheng,X.-L.; Sun,H.-X.; Liu,X.-L.,Chen,Y.-X.; Qian,B.-C.Acta Pharmacol.Sin.2004,25,1090.
  • 10Geary,W.J.Coord.Chem.Rev.1971,7,81.

二级参考文献92

  • 1赵刚,高等学校化学学报,1990年,11卷,1327页
  • 2Mei H Y,Natl Acad Sci USA,1988年,85卷,1339页
  • 3Satyanarayana, S.; Dabrowiak, J. C.; Chaires, J. B. Biochemistry 1992, 31(39), 9319.
  • 4Wahnon, D.; Hynes, R. C.; Chin, J. J. Chem. Soc., Chem.Commun. 1994, 1441.
  • 5Mokhir, A. A.; Kraemer, R. Bioconjugate Chem. 2003, 14,877.
  • 6Cheng, C. C.; Fu, W. C. H.; Hung, K. C.; Chen, P. J.; Wang,W. J.; Chen, Y. T. Nucleic Acids Res. 2003, 31(8), 2227.
  • 7Liu, F.; Wang, K.; Bai, G.; Zhang, Y.; Gao, L. Inorg. Chem.2004, 43(5), 1799.
  • 8Okamoto, A.; Tanabe, K.; Saito, L. J. Am. Chem. Soc. 2002,124, 10262.
  • 9Wu, T. Z.; Yuan, L. J. Inorg. Biochem. 2004, 98(1), 41.
  • 10Liu, J.; Mei, W. J.; Lin, L. J.; Zheng, K. C.; Chao, H.; Yun,F. C.; Ji, L. N. Inorg. Chim. Acta 2004, 357(1), 285.

共引文献141

同被引文献43

  • 1王锡森,宋玉梅,熊仁根.含有抗菌药物诺氟沙星的金属有机羰基钼配合物(英文)[J].无机化学学报,2005,21(8):1270-1274. 被引量:3
  • 2王云霞.环丙氟哌酸临床应用及与其他药物的相互作用[J].中国误诊学杂志,2005,5(14):2781-2782. 被引量:1
  • 3白林,黄晓舞.差示分光光度法测定盐酸环丙氟哌酸制剂的含量[J].中国药业,2006,15(20):25-26. 被引量:1
  • 4Gao F,Yang P,Xie J. Synthesis,characterization and antibacterial activity of novel Fe(Ⅲ),Co(Ⅱ),and Zn(Ⅱ) Complexes with norfloxacin[J].J Inorg Biochem,1995,(01):61-67.
  • 5Wang Yucheng,Zhao Hong,Ye Qiong. Novel 2D supramolecular array based on antibacterial drug norfloxacin[J].Inorganica Chimica Acta,2004.4303-4308.
  • 6Wei Yongqin,Zhou Zhangfeng,Zhuang Botao. The mixed-ligand copper(Ⅱ) complex(2,2-bipyridine)-[1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-4-ium-1-yl) quinolone-3-carboxylato]nitratocopper(Ⅱ)nitratedehydrate[J].Acta Cryst,2005.m66-m68.
  • 7Eleni K Efthimiadou,Hellinida Thomadaki,Yiannis Sanakis. Structure and biological properties of the copper(Ⅱ)complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2'-bipyridine[J].Journal of Inorganic Biochemistry,2006,(01):64-73.
  • 8Eleni K Efthimiadou,George Psomas,Yiannis Sanakis. Metal complexes with the quinolone antibacterial agent N-propyl-norfloxacin:Synthesis,structure and bioactivity[J].Journal of Inorganic Biochemistry,2007.525-535.
  • 9I ztok Turel,Ljubo Goli,Peter Bukovec. Antibacterial tests of Bismuth(Ⅲ)-Quinolone(Ciprofloxacin,cf) compounds against Helicobacter pylori and some other bacteria.Crystal structure of(cfH2) 2[Bi2 Cl10]4H2O[J].Journal of Inorganic Biochemistry,1998.53-60.
  • 10Saha D K,Padhye S,Anson C E. Hydrothermal synthesis,crystal structure,spectroscopy,electrochemistry and antimycobacterial evaluation of the copper(Ⅱ) ciprofloxacin complex:[Cu(cf) 2(BF4) 2]6H2O[J].Inorganic Chemistry Communications,2002,(05):1022.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部